Heart failure caused by Takayasu's arteritis in the time of COVID‐19: a case report
Abstract The case of a 35‐year‐old female with heart failure is presented, where the symptoms overlap with the heterogeneous manifestations of coronavirus disease 2019 (COVID‐19). Those similarities and a recent shift in priorities during the SARS‐CoV‐2 pandemic delayed the recognition of acute hear...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-10-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.14054 |
| _version_ | 1797794282414800896 |
|---|---|
| author | Ágnes Orsolya Rácz Gábor Tamás Szabó Nóra Erdei Ferenc Győry Rudolf Viktor Kolozsvári |
| author_facet | Ágnes Orsolya Rácz Gábor Tamás Szabó Nóra Erdei Ferenc Győry Rudolf Viktor Kolozsvári |
| author_sort | Ágnes Orsolya Rácz |
| collection | DOAJ |
| description | Abstract The case of a 35‐year‐old female with heart failure is presented, where the symptoms overlap with the heterogeneous manifestations of coronavirus disease 2019 (COVID‐19). Those similarities and a recent shift in priorities during the SARS‐CoV‐2 pandemic delayed the recognition of acute heart failure in this patient. During the differential diagnostic process, obliterative disease was discovered in the bilateral subclavian and right renal arteries, and the latter resulted in uncontrolled hypertension, which played a significant role in the development of heart failure. The aetiology of vascular alterations turned out to be Takayasu's arteritis. Diagnosing Takayasu's arteritis is typically not straightforward due to its nonspecific signs and symptoms. Therefore, it can be concluded from our case report that the rising incidence of COVID‐19 and focus on ruling out infection can potentially defer alternative, but appropriate diagnostic tests, particularly for certain conditions like rare diseases. Early identification and intervention is especially important for treating acute heart failure, whereas delay increases the risk of severe complications and mortality. |
| first_indexed | 2024-03-13T03:00:28Z |
| format | Article |
| id | doaj.art-50b6aa124cb041b0a37885deaaed7b35 |
| institution | Directory Open Access Journal |
| issn | 2055-5822 |
| language | English |
| last_indexed | 2024-03-13T03:00:28Z |
| publishDate | 2022-10-01 |
| publisher | Wiley |
| record_format | Article |
| series | ESC Heart Failure |
| spelling | doaj.art-50b6aa124cb041b0a37885deaaed7b352023-06-27T14:49:57ZengWileyESC Heart Failure2055-58222022-10-01953602360710.1002/ehf2.14054Heart failure caused by Takayasu's arteritis in the time of COVID‐19: a case reportÁgnes Orsolya Rácz0Gábor Tamás Szabó1Nóra Erdei2Ferenc Győry3Rudolf Viktor Kolozsvári4Division of Cardiology, Department of Cardiology, Faculty of Medicine University of Debrecen Debrecen HungaryDivision of Cardiology, Department of Cardiology, Faculty of Medicine University of Debrecen Debrecen HungaryDivision of Cardiology, Department of Cardiology, Faculty of Medicine University of Debrecen Debrecen HungaryDivision of Cardiology, Department of Cardiology, Faculty of Medicine University of Debrecen Debrecen HungaryDivision of Cardiology, Department of Cardiology, Faculty of Medicine University of Debrecen Debrecen HungaryAbstract The case of a 35‐year‐old female with heart failure is presented, where the symptoms overlap with the heterogeneous manifestations of coronavirus disease 2019 (COVID‐19). Those similarities and a recent shift in priorities during the SARS‐CoV‐2 pandemic delayed the recognition of acute heart failure in this patient. During the differential diagnostic process, obliterative disease was discovered in the bilateral subclavian and right renal arteries, and the latter resulted in uncontrolled hypertension, which played a significant role in the development of heart failure. The aetiology of vascular alterations turned out to be Takayasu's arteritis. Diagnosing Takayasu's arteritis is typically not straightforward due to its nonspecific signs and symptoms. Therefore, it can be concluded from our case report that the rising incidence of COVID‐19 and focus on ruling out infection can potentially defer alternative, but appropriate diagnostic tests, particularly for certain conditions like rare diseases. Early identification and intervention is especially important for treating acute heart failure, whereas delay increases the risk of severe complications and mortality.https://doi.org/10.1002/ehf2.14054Acute heart failureTakayasu's arteritisCOVID‐19 |
| spellingShingle | Ágnes Orsolya Rácz Gábor Tamás Szabó Nóra Erdei Ferenc Győry Rudolf Viktor Kolozsvári Heart failure caused by Takayasu's arteritis in the time of COVID‐19: a case report ESC Heart Failure Acute heart failure Takayasu's arteritis COVID‐19 |
| title | Heart failure caused by Takayasu's arteritis in the time of COVID‐19: a case report |
| title_full | Heart failure caused by Takayasu's arteritis in the time of COVID‐19: a case report |
| title_fullStr | Heart failure caused by Takayasu's arteritis in the time of COVID‐19: a case report |
| title_full_unstemmed | Heart failure caused by Takayasu's arteritis in the time of COVID‐19: a case report |
| title_short | Heart failure caused by Takayasu's arteritis in the time of COVID‐19: a case report |
| title_sort | heart failure caused by takayasu s arteritis in the time of covid 19 a case report |
| topic | Acute heart failure Takayasu's arteritis COVID‐19 |
| url | https://doi.org/10.1002/ehf2.14054 |
| work_keys_str_mv | AT agnesorsolyaracz heartfailurecausedbytakayasusarteritisinthetimeofcovid19acasereport AT gabortamasszabo heartfailurecausedbytakayasusarteritisinthetimeofcovid19acasereport AT noraerdei heartfailurecausedbytakayasusarteritisinthetimeofcovid19acasereport AT ferencgyory heartfailurecausedbytakayasusarteritisinthetimeofcovid19acasereport AT rudolfviktorkolozsvari heartfailurecausedbytakayasusarteritisinthetimeofcovid19acasereport |